{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:55:27Z","timestamp":1788411327286,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIHR Clinical Lectureship"},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Research Council"},{"DOI":"10.13039\/501100017506","name":"Alzheimer\u2019s Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017506","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Union\u2019s Horizon Europe research and innovation program"},{"DOI":"10.13039\/100021066","name":"Gates Ventures","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100021066","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish government and the County Councils"},{"name":"ALF-agreement"},{"DOI":"10.13039\/501100003792","name":"Swedish Brain Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Swedish Alzheimer Foundation"},{"name":"Sahlgrenska Academy at the University of Gothenburg"},{"name":"V\u00e4stra G\u00f6taland Region R&D"},{"name":"Sahlgrenska Science Park"},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIHR Advanced Fellowship"},{"name":"Imperial College London NIHR Biomedical Research Centre"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Determining whether MRI brain scans demonstrate atrophy that is beyond \u201cnormal for age\u201d is challenging. Automated measurements of structural metrics in individual brain regions have shown promise as biomarkers of neurodegeneration, yet widely available reference standards that aid interpretation at the individual level are lacking. Normative modelling, enabling standardized \u201cbrain charts\u201d, represents a significant step in addressing this challenge by generating individualized age- and sex- adjusted centile scores derived from large, aggregated datasets for MRI-derived quantitative metrics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using normative data from 56,173 participants across the life course, we have developed regional cortical thickness and amygdala\/hippocampal volume brain charts (adjusted for total intracranial volume) that can be applied at the individual level. At the group level, we investigate whether regional centile scores relate to cognitive performance (mini-mental state examination) and discriminate individuals with neuropathological evidence of Alzheimer\u2019s disease (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009351) from propensity-matched controls from the National Alzheimer's Coordinating Center (NACC) dataset. In addition, we explored the relationships between disease stage, cognition, regional tau deposition and regional centile scores in amyloid-\u03b2-PET-positive individuals with Alzheimer\u2019s disease dementia (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200939) and mild cognitive impairment (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200971) from the Alzheimer\u2019s Disease Neuroimaging Initiative-3 (ADNI-3). We then extended this approach to phenotypes of frontotemporal lobar degeneration using the Neuroimaging in Frontotemporal Dementia dataset (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009113).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We demonstrate BrainChart\u2019s application to illustrative individual cases. At the group level, we show that in Alzheimer\u2019s disease, regional centile scores from brain charting predicted cognitive performance, temporal lobe tau PET tracer uptake and discriminated disease groups from propensity matched cognitively normal controls in independent cohorts. Distinct patterns of age-inappropriate cortical atrophy were also evident in different clinical phenotypes of frontotemporal lobar degeneration from the Neuroimaging in Frontotemporal Dementia dataset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Regional centile scores derived from an extensive normative dataset represent a generalizable method for objectively identifying atrophy in neurodegenerative diseases and can be applied to determine neurodegenerative atrophy at the individual level.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-025-01872-x","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:44:22Z","timestamp":1762962262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Generalizable MRI normative modelling to detect age-inappropriate neurodegeneration"],"prefix":"10.1186","volume":"17","author":[{"given":"Thomas D.","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A. I.","family":"Bethlehem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Seidlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon R.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C. B.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena A.","family":"Kolanko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Bernstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Dorfschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Bourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Gailly de Taurines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Del Giovane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S. N.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan J. F.","family":"Losty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sch\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Srikrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paresh A.","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh C.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron F.","family":"Alexander-Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Bullmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Frontotemporal Lobar Degeneration Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford C.","family":"Dickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimoko","family":"Domoto-Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Knopman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley F.","family":"Boeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kornak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Luisa","family":"Gorno-Tempini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Mandelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Lifespan Brain Chart Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"9406","key":"1872_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0140-6736(04)15441-X","volume":"363","author":"NC Fox","year":"2004","unstructured":"Fox NC, Schott JM. Imaging cerebral atrophy: normal ageing to Alzheimer\u2019s disease. Lancet. 2004;363(9406):392\u20134.","journal-title":"Lancet"},{"issue":"6","key":"1872_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/jnnp-2013-306285","volume":"85","author":"L Harper","year":"2014","unstructured":"Harper L, Barkhof F, Scheltens P, Schott JM, Fox NC. An algorithmic approach to structural imaging in dementia. J Neurol Neurosurg Psychiatry. 2014;85(6):692\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 12","key":"1872_CR3","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1093\/brain\/awv283","volume":"138","author":"CR Jack","year":"2015","unstructured":"Jack CR, Wiste HJ, Weigand SD, Knopman DS, Mielke MM, Vemuri P, et al. Different definitions of neurodegeneration produce similar amyloid\/neurodegeneration biomarker group findings. Brain. 2015;138(Pt 12):3747\u201359.","journal-title":"Brain"},{"key":"1872_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.nicl.2016.05.017","volume":"11","author":"CG Schwarz","year":"2016","unstructured":"Schwarz CG, Gunter JL, Wiste HJ, Przybelski SA, Weigand SD, Ward CP, et al. A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer\u2019s disease severity. NeuroImage: Clinical. 2016;11:802\u201312.","journal-title":"NeuroImage: Clinical"},{"issue":"7","key":"1872_CR5","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1007\/s00330-020-07455-8","volume":"31","author":"HG Pemberton","year":"2021","unstructured":"Pemberton HG, Goodkin O, Prados F, Das RK, Vos SB, Moggridge J, et al. Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study. Eur Radiol. 2021;31(7):5312\u201323.","journal-title":"Eur Radiol"},{"key":"1872_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neurobiolaging.2016.05.024","volume":"52","author":"M Ten Kate","year":"2017","unstructured":"Ten Kate M, Barkhof F, Boccardi M, Visser PJ, Jack CR, Lovblad KO, et al. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer\u2019s disease in the context of a structured 5-phase development framework. Neurobiol Aging. 2017;52:167-182.e1.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"1872_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fnagi.2017.00117","volume":"9","author":"HFM Rhodius-Meester","year":"2017","unstructured":"Rhodius-Meester HFM, Benedictus MR, Wattjes MP, Barkhof F, Scheltens P, Muller M, et al. MRI visual ratings of brain atrophy and white matter hyperintensities across the spectrum of cognitive decline are differently affected by age and diagnosis. Front Aging Neurosci. 2017;9(9):117.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"1872_CR8","doi-asserted-by":"publisher","first-page":"e01662","DOI":"10.1002\/brb3.1662","volume":"10","author":"V Velickaite","year":"2020","unstructured":"Velickaite V, Ferreira D, Lind L, Ahlstr\u00f6m H, Kilander L, Westman E, et al. Visual rating versus volumetry of regional brain atrophy and longitudinal changes over a 5-year period in an elderly population. Brain Behav. 2020;10(7):e01662.","journal-title":"Brain Behav"},{"issue":"4","key":"1872_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/acn3.51749","volume":"10","author":"F Loreto","year":"2023","unstructured":"Loreto F, Gontsarova A, Scott G, Patel N, Win Z, Carswell C, et al. Visual atrophy rating scales and amyloid PET status in an Alzheimer\u2019s disease clinical cohort. Ann Clin Transl Neurol. 2023;10(4):619\u201331.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"1872_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/WNL.0b013e31823efc6c","volume":"78","author":"BC Dickerson","year":"2012","unstructured":"Dickerson BC, Wolk DA. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology. 2012;78(2):84\u201390.","journal-title":"Neurology"},{"issue":"3","key":"1872_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cercor\/bhn113","volume":"19","author":"BC Dickerson","year":"2009","unstructured":"Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, et al. The cortical signature of Alzheimer\u2019s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009;19(3):497\u2013510.","journal-title":"Cereb Cortex"},{"issue":"6","key":"1872_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","volume":"16","author":"CR Jack","year":"2017","unstructured":"Jack CR, Wiste HJ, Weigand SD, Therneau TM, Knopman DS, Lowe V, et al. Age-specific and sex-specific prevalence of cerebral \u03b2-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study. Lancet Neurol. 2017;16(6):435\u201344.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1872_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9(2):179\u201394.","journal-title":"Neuroimage"},{"issue":"20","key":"1872_CR14","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000;97(20):11050\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"524","key":"1872_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5732","volume":"12","author":"R La Joie","year":"2020","unstructured":"La Joie R, Visani AV, Baker SL, Brown JA, Bourakova V, Cha J, et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12(524):eaau5732.","journal-title":"Sci Transl Med"},{"issue":"7","key":"1872_CR16","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","volume":"52","author":"CR Jack","year":"1999","unstructured":"Jack CR, Petersen RC, Xu YC, O\u2019Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52(7):1397\u20131397.","journal-title":"Neurology"},{"key":"1872_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","volume":"30","author":"L Pini","year":"2016","unstructured":"Pini L, Pievani M, Bocchetta M, Altomare D, Bosco P, Cavedo E, et al. Brain atrophy in Alzheimer\u2019s disease and aging. Ageing Res Rev. 2016;30:25\u201348.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1872_CR18","doi-asserted-by":"publisher","first-page":"15746","DOI":"10.1038\/s41598-021-95098-0","volume":"11","author":"WHL Pinaya","year":"2021","unstructured":"Pinaya WHL, Scarpazza C, Garcia-Dias R, Vieira S, Baecker L, F da Costa P, et al. Using normative modelling to detect disease progression in mild cognitive impairment and Alzheimer\u2019s disease in a cross-sectional multi-cohort study. Sci Rep. 2021;11(1):15746.","journal-title":"Sci Rep."},{"issue":"24","key":"1872_CR19","doi-asserted-by":"publisher","first-page":"e2442","DOI":"10.1212\/WNL.0000000000207298","volume":"100","author":"S Verdi","year":"2023","unstructured":"Verdi S, Kia SM, Yong KXX, Tosun D, Schott JM, Marquand AF, et al. Revealing Individual Neuroanatomical Heterogeneity in Alzheimer Disease Using Neuroanatomical Normative Modeling. Neurology. 2023;100(24):e2442\u201353.","journal-title":"Neurology"},{"issue":"23","key":"1872_CR20","doi-asserted-by":"publisher","first-page":"101904","DOI":"10.1016\/j.nicl.2019.101904","volume":"19","author":"L Nobis","year":"2019","unstructured":"Nobis L, Manohar SG, Smith SM, Alfaro-Almagro F, Jenkinson M, Mackay CE, et al. Hippocampal volume across age: Nomograms derived from over 19,700 people in UK Biobank. Neuroimage Clin. 2019;19(23):101904.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"1872_CR21","doi-asserted-by":"publisher","first-page":"e12559","DOI":"10.1002\/dad2.12559","volume":"16","author":"F Loreto","year":"2024","unstructured":"Loreto F, Verdi S, Kia SM, Duvnjak A, Hakeem H, Fitzgerald A, et al. Alzheimer\u2019s disease heterogeneity revealed by neuroanatomical normative modeling. Alzheimers Dement (Amst). 2024;16(1):e12559.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"1872_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/hbm.25364","volume":"43","author":"S Frangou","year":"2022","unstructured":"Frangou S, Modabbernia A, Williams SCR, Papachristou E, Doucet GE, Agartz I, et al. Cortical thickness across the lifespan: data from 17,075 healthy individuals aged 3\u201390 years. Hum Brain Mapp. 2022;43(1):431\u201351.","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"1872_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1176\/appi.ajp.2017.17010100","volume":"175","author":"D van Rooij","year":"2018","unstructured":"van Rooij D, Anagnostou E, Arango C, Auzias G, Behrmann M, Busatto GF, et al. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD Working Group. Am J Psychiatry. 2018;175(4):359\u201369.","journal-title":"Am J Psychiatry"},{"key":"1872_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.12688\/wellcomeopenres.19591.1","volume":"8","author":"P Barkema","year":"2023","unstructured":"Barkema P, Rutherford S, Lee HC, Kia SM, Savage H, Beckmann C, et al. Predictive Clinical Neuroscience Portal (PCNportal): instant online access to research-grade normative models for clinical neuroscientists. Wellcome Open Res. 2023;8:326.","journal-title":"Wellcome Open Res"},{"issue":"11","key":"1872_CR25","doi-asserted-by":"publisher","first-page":"5501","DOI":"10.1002\/hbm.23743","volume":"38","author":"P Coup\u00e9","year":"2017","unstructured":"Coup\u00e9 P, Catheline G, Lanuza E, Manj\u00f3n JV, Alzheimer\u2019s Disease Neuroimaging Initiative. Towards a unified analysis of brain maturation and aging across the entire lifespan: a MRI analysis. Hum Brain Mapp. 2017;38(11):5501\u201318.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"1872_CR26","doi-asserted-by":"publisher","first-page":"fcac109","DOI":"10.1093\/braincomms\/fcac109","volume":"4","author":"V Planche","year":"2022","unstructured":"Planche V, Manjon JV, Mansencal B, Lanuza E, Tourdias T, Catheline G, et al. Structural progression of Alzheimer\u2019s disease over decades: the MRI staging scheme. Brain Commun. 2022;4(3):fcac109.","journal-title":"Brain Commun"},{"issue":"8","key":"1872_CR27","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1002\/alz.12975","volume":"19","author":"V Planche","year":"2023","unstructured":"Planche V, Mansencal B, Manjon JV, Tourdias T, Catheline G, Coup\u00e9 P. Anatomical MRI staging of frontotemporal dementia variants. Alzheimers Dement. 2023;19(8):3283\u201394.","journal-title":"Alzheimers Dement"},{"key":"1872_CR28","unstructured":"Planche V, Mansencal B, Fonov V, Manjon JV, Tourdias T, Bouzigues A, et al. Anatomical progression of genetic frontotemporal lobar degeneration across the lifespan. Brain. 2025;awaf195."},{"issue":"10","key":"1872_CR29","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1002\/hbm.25850","volume":"43","author":"P Coup\u00e9","year":"2022","unstructured":"Coup\u00e9 P, Manj\u00f3n JV, Mansencal B, Tourdias T, Catheline G, Planche V. Hippocampal-amygdalo-ventricular atrophy score: Alzheimer disease detection using normative and pathological lifespan models. Hum Brain Mapp. 2022;43(10):3270\u201382.","journal-title":"Hum Brain Mapp"},{"issue":"7906","key":"1872_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41586-022-04554-y","volume":"604","author":"RAI Bethlehem","year":"2022","unstructured":"Bethlehem RAI, Seidlitz J, White SR, Vogel JW, Anderson KM, Adamson C, et al. Brain charts for the human lifespan. Nature. 2022;604(7906):525\u201333.","journal-title":"Nature."},{"key":"1872_CR31","first-page":"1","volume":"23","author":"DM Stasinopoulos","year":"2008","unstructured":"Stasinopoulos DM, Rigby RA. Generalized Additive Models for Location Scale and Shape (GAMLSS) in R. J Stat Softw. 2008;23:1\u201346.","journal-title":"J Stat Softw"},{"issue":"6","key":"1872_CR32","doi-asserted-by":"publisher","first-page":"e43777","DOI":"10.2196\/43777","volume":"9","author":"MCB David","year":"2023","unstructured":"David MCB, Kolanko M, Del Giovane M, Lai H, True J, Beal E, et al. Remote monitoring of physiology in people living with dementia: an observational cohort study. JMIR Aging. 2023;9(6):e43777.","journal-title":"JMIR Aging"},{"issue":"4","key":"1872_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","volume":"71","author":"TG Beach","year":"2012","unstructured":"Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005\u20132010. J Neuropathol Exp Neurol. 2012;71(4):266\u201373.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"104","key":"1872_CR34","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.neuroimage.2014.09.034","volume":"1","author":"IB Malone","year":"2015","unstructured":"Malone IB, Leung KK, Clegg S, Barnes J, Whitwell JL, Ashburner J, et al. Accurate automatic estimation of total intracranial volume: A nuisance variable with less nuisance. Neuroimage. 2015;1(104):366\u201372.","journal-title":"Neuroimage"},{"key":"1872_CR35","doi-asserted-by":"publisher","unstructured":"Montagnese M, Ebneabbasi A, Garc\u00eda-San-Mart\u00edn N, Pecci-Terroba C, Romero-Garc\u00eda R, Morgan SE, et al. Structural Similarity Networks Reveal Brain Vulnerability in Dementia. medRxiv; 2025. p. 2025.06.10.25328978. Available from: https:\/\/www.medrxiv.org\/content\/https:\/\/doi.org\/10.1101\/2025.06.10.25328978v1. Cited 2025 Aug 23.","DOI":"10.1101\/2025.06.10.25328978v1"},{"key":"1872_CR36","doi-asserted-by":"publisher","unstructured":"Visualization of Brain Statistics With R Packages ggseg and ggseg3d - Athanasia M. Mowinckel, Didac Vidal-Pi\u00f1eiro, 2020. Available from: https:\/\/journals.sagepub.com\/doi\/full\/https:\/\/doi.org\/10.1177\/2515245920928009. Cited 2024 Feb 19.","DOI":"10.1177\/2515245920928009"},{"issue":"3","key":"1872_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for alzheimer disease pathology. JAMA Neurol. 2024;81(3):255\u201363.","journal-title":"JAMA Neurol"},{"key":"1872_CR38","unstructured":"Lee J, Ward T, Harrison T, Landau S. ADNI Tau PET Processing Methods. 2023. Available from: https:\/\/ida.loni.usc.edu\/login.jsp?project=ADNI"},{"issue":"6","key":"1872_CR39","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1007\/s00415-018-8762-6","volume":"265","author":"CR Marshall","year":"2018","unstructured":"Marshall CR, Hardy CJD, Volkmer A, Russell LL, Bond RL, Fletcher PD, et al. Primary progressive aphasia: a clinical approach. J Neurol. 2018;265(6):1474\u201390.","journal-title":"J Neurol"},{"issue":"2","key":"1872_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/09540261.2013.778822","volume":"25","author":"JD Rohrer","year":"2013","unstructured":"Rohrer JD, Rosen HJ. Neuroimaging in frontotemporal dementia. Int Rev Psychiatry. 2013;25(2):221\u20139.","journal-title":"Int Rev Psychiatry"},{"issue":"5","key":"1872_CR41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, et al. PET Imaging of Tau Deposition in the Aging Human Brain. Neuron. 2016;89(5):971\u201382.","journal-title":"Neuron"},{"issue":"9","key":"1872_CR42","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/brain\/awx171","volume":"140","author":"M Sch\u00f6ll","year":"2017","unstructured":"Sch\u00f6ll M, Ossenkoppele R, Strandberg O, Palmqvist S, Swedish BioFINDER study, J\u00f6gi J, et al. Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer\u2019s disease. Brain. 2017;140(9):2286\u201394.","journal-title":"Brain."},{"key":"1872_CR43","doi-asserted-by":"crossref","unstructured":"Struyfs H, Sima DM, Wittens M, Ribbens A, Pedrosa de Barros N, Phan TV, et al. Automated MRI volumetry as a diagnostic tool for Alzheimer\u2019s disease: Validation of icobrain dm. Neuroimage Clin. 2020;26:102243.","DOI":"10.1016\/j.nicl.2020.102243"},{"issue":"1","key":"1872_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1176\/appi.neuropsych.11120377","volume":"25","author":"DE Ross","year":"2013","unstructured":"Ross DE, Ochs AL, Seabaugh JM, Shrader CR. Man versus machine: comparison of radiologists\u2019 interpretations and NeuroQuant\u00ae volumetric analyses of brain MRIs in patients with traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2013;25(1):32\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"7","key":"1872_CR45","doi-asserted-by":"publisher","first-page":"e960","DOI":"10.1002\/ctm2.960","volume":"12","author":"SA Bedford","year":"2022","unstructured":"Bedford SA, Seidlitz J, Bethlehem RAI. Translational potential of human brain charts. Clin Transl Med. 2022;12(7):e960.","journal-title":"Clin Transl Med"},{"issue":"1","key":"1872_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"1872_CR47","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330(6):512\u201327.","journal-title":"JAMA"},{"issue":"4","key":"1872_CR48","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00234-021-02862-0","volume":"64","author":"P Filip","year":"2022","unstructured":"Filip P, Bednarik P, Eberly LE, Moheet A, Svatkova A, Grohn H, et al. Different FreeSurfer versions might generate different statistical outcomes in case-control comparison studies. Neuroradiology. 2022;64(4):765\u201373.","journal-title":"Neuroradiology"},{"issue":"86","key":"1872_CR49","doi-asserted-by":"publisher","first-page":"102789","DOI":"10.1016\/j.media.2023.102789","volume":"1","author":"B Billot","year":"2023","unstructured":"Billot B, Greve DN, Puonti O, Thielscher A, Van Leemput K, Fischl B, et al. SynthSeg: Segmentation of brain MRI scans of any contrast and resolution without retraining. Med Image Anal. 2023;1(86):102789.","journal-title":"Med Image Anal"},{"issue":"15","key":"1872_CR50","doi-asserted-by":"publisher","first-page":"100321","DOI":"10.1016\/j.lanepe.2022.100321","volume":"1","author":"PLK Bothongo","year":"2022","unstructured":"Bothongo PLK, Jitlal M, Parry E, Waters S, Foote IF, Watson CJ, et al. Dementia risk in a diverse population: a single-region nested case-control study in the East End of London. The Lancet Regional Health - Europe. 2022;1(15):100321.","journal-title":"The Lancet Regional Health - Europe"},{"issue":"2\u20133","key":"1872_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1017\/S0140525X0999152X","volume":"33","author":"J Henrich","year":"2010","unstructured":"Henrich J, Heine SJ, Norenzayan A. The weirdest people in the world? Behav Brain Sci. 2010;33(2\u20133):61\u201383 (discussion 83-135).","journal-title":"Behav Brain Sci."},{"issue":"1","key":"1872_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13195-021-00928-y","volume":"13","author":"ML Alosco","year":"2021","unstructured":"Alosco ML, Mian AZ, Buch K, Farris CW, Uretsky M, Tripodis Y, et al. Structural MRI profiles and tau correlates of atrophy in autopsy-confirmed CTE. Alzheimers Res Ther. 2021;13(1):193.","journal-title":"Alzheimers Res Ther"},{"issue":"Pt 10","key":"1872_CR53","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1093\/brain\/awv211","volume":"138","author":"E Mak","year":"2015","unstructured":"Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, et al. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. Brain. 2015;138(Pt 10):2974\u201386.","journal-title":"Brain"},{"issue":"18","key":"1872_CR54","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.nicl.2018.03.002","volume":"2","author":"J Machts","year":"2018","unstructured":"Machts J, Cardenas-Blanco A, Acosta-Cabronero J, Kaufmann J, Loewe K, Kasper E, et al. Prefrontal cortical thickness in motor neuron disease. Neuroimage Clin. 2018;2(18):648\u201355.","journal-title":"Neuroimage Clin"},{"issue":"189","key":"1872_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106354","volume":"1","author":"K Li","year":"2023","unstructured":"Li K, Luo X, Zeng Q, Liu X, Li J, Zhong S, et al. Gray matter structural covariance networks patterns associated with autopsy-confirmed LATE-NC compared to Alzheimer\u2019s disease pathology. Neurobiol Dis. 2023;1(189):106354.","journal-title":"Neurobiol Dis"},{"key":"1872_CR56","doi-asserted-by":"publisher","unstructured":"Dorfschmidt L, White S, Gardner M, Bedford S, Ball G, Edwards AD, et al. Charting structural brain asymmetry across the human lifespan. bioRxiv; 2025. p. 2025.07.21.665924. Available from: https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/2025.07.21.665924v1. Cited 2025 Aug 12.","DOI":"10.1101\/2025.07.21.665924v1"},{"key":"1872_CR57","doi-asserted-by":"crossref","unstructured":"Di\u00a0Biase MA, Tian YE, Bethlehem RAI, Seidlitz J, Alexander-Bloch Aaron F, Yeo BTT, et al. Mapping human brain charts cross-sectionally and longitudinally. Proc Natl Acad Sci U S A. 2023;120(20):e2216798120.","DOI":"10.1073\/pnas.2216798120"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01872-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01872-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T17:03:41Z","timestamp":1762967021000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01872-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1872"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01872-x","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent was obtained from all participants included in this paper by the relevant study team. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): All ADNI participants provided written informed consent at the time of enrollment. The study protocols were approved by the Institutional Review Boards (IRBs) of all participating institutions. Data collection and sharing procedures comply with ethical standards for human research and protect participant confidentiality. National Alzheimer\u2019s Coordinating Center (NACC): Data were obtained from the NACC database, which aggregates data collected from Alzheimer\u2019s Disease Centers across the United States. Each center obtained IRB approval for data collection and informed consent from participants or their legally authorized representatives. All data shared by NACC are de-identified to ensure privacy. Neuroimaging Frontotemporal Dementia (NIFD) Initiative: NIFD participants provided written informed consent under protocols approved by the respective local ethics committees. Data collection adhered to ethical guidelines consistent with the Declaration of Helsinki, and shared datasets are anonymized to protect participant confidentiality.Minder study: Health Research Authority\u2019s London-Surrey Borders Research Ethics Committee\u201419\/LO\/0102.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants (or their legal guardians) provided written informed consent for participation in the study and for publication of the anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R.A.I.B, J.S., S.R.W., J.D.B., M.Sc., M.Sr., A.F.A.-B., and E.T.B. are co-founders and have equity in Centile Bioscience. E.T.B. has consulted for Novartis, Boehringer Ingelheim, GlaxoSmithKline, SR One and Monument Therapeutics. J.D.B. has an equity position in Treovir Inc. and UpFront Diagnostics. J.D.B. is also on the NeuroX1 and QV Bioelectronics scientific advisory boards. M.Sc. has served on advisory boards for Roche and Novo Nordisk, received speaker honoraria from Bioarctic, Eisai, Genentech, Novo Nordisk and Roche and receives research support (to the institution) from Alzpath, Bioarctic, Novo Nordisk and Roche (outside scope of submitted work). He serves as Associate Editor with Alzheimer\u2019s Research & Therapy.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}